[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@MularskiOlek Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::968914433568378882.png) @MularskiOlek Olek Mularski

Olek Mularski posts on X about buyback, $21bn, $340m, novo the most. They currently have XX followers and XXX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::968914433568378882/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::968914433568378882/c:line/m:interactions.svg)

- X Week XXX -XX%
- X Month XXX +48%
- X Months XXXXX -XX%
- X Year XXXXX +70%

### Mentions: X [#](/creator/twitter::968914433568378882/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::968914433568378882/c:line/m:posts_active.svg)

- X Week XX +56%
- X Month XX +67%
- X Months XXX +123%
- X Year XXX +101%

### Followers: XX [#](/creator/twitter::968914433568378882/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::968914433568378882/c:line/m:followers.svg)

- X Week XX +2.10%
- X Month XX -X%
- X Months XX +24%
- X Year XX -XX%

### CreatorRank: undefined [#](/creator/twitter::968914433568378882/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::968914433568378882/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::968914433568378882/influence)
---

**Social category influence**
[stocks](/list/stocks) 

**Social topic influence**
[buyback](/topic/buyback), [$21bn](/topic/$21bn), [$340m](/topic/$340m), [novo](/topic/novo)
### Top Social Posts [#](/creator/twitter::968914433568378882/posts)
---
Top posts by engagements in the last XX hours

"@commerzbank AG is kicking off a share buyback worth as much as X billion ($1.2 billion) after securing the necessary approvals from regulators"  
[X Link](https://x.com/MularskiOlek/status/1971112218810024218) [@MularskiOlek](/creator/x/MularskiOlek) 2025-09-25T07:19Z XX followers, XXX engagements


"@novonordisk agreed to pay Omeros as much as $2.1bn for rights to an experimental rare-disease drug as Novo continues to use deal-making to build its pipeline. Omeros will receive $340m in cash with the rest tied to milestones Zaltenibart is for rare blood and kidney disorders"  
[X Link](https://x.com/MularskiOlek/status/1978740950395461696) [@MularskiOlek](/creator/x/MularskiOlek) 2025-10-16T08:33Z XX followers, XX engagements